GlassScriptPhysician profile
Mansour Razminia
NPI 1891802203
$926,874.33
in general payments reported to CMS, 2019-2025
16 companies · $120K in 2025
The $120K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233K · 2020: $128K · 2021: $99K · 2022: $112K · 2023: $109K · 2024: $125K · 2025: $120K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $256K · Travel and Lodging: $66K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $23K · Food and Beverage: $9,802 · Education: $15.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $255,585.10 |
| Travel and Lodging | $65,555.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,356.25 |
| Food and Beverage | $9,801.57 |
| Education | $15.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $785,926.62 | 2019-2025 | Na, Ensite Precision, Ensite |
| Boston Scientific Corporation | $84,868.01 | 2021-2025 | Versacross Access Solution, Ultra Ice Plus, Icefx Cryoablation System |
| Baylis Medical Company INC | $37,857.48 | 2020-2021 | |
| Circa Scientific, INC. | $10,000.00 | 2019 | |
| Medtronic, INC. | $5,426.14 | 2024-2025 | Micra, Affera Mapping System |
| Altathera Pharmaceuticals LLC | $1,961.08 | 2025 | Sotalol Hydrochloride |
| Biotronik INC. | $283.62 | 2019-2022 | |
| Biosense Webster, INC. | $170.35 | 2024 | Nuvision Ice Catheter, Carto 3 |
| Cardiva Medical, INC. | $130.70 | 2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Shockwave Medical, INC | $59.41 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $59.14 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $33.12 | 2023-2025 | Camzyos, Abilify |
| Kestra Medical Technology Services, INC. | $30.98 | 2025 | Assure Wcd |
| Integra Lifesciences Corporation | $28.22 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Pfizer INC. | $23.13 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.33 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mansour Razminia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.